Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · IEX Real-Time Price · USD

51.54

-3.78 (-6.83%)

At close: Jul 2, 2024, 4:00 PM

51.77

+0.23 (0.45%)

After-hours: Jul 2, 2024, 7:57 PM EDT

Viking Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-85.9	-68.87	-54.99	-39.5	-25.78	Upgrade
Depreciation & Amortization	0.29	0.29	0.3	0.28	0.26	Upgrade
Share-Based Compensation	16.75	8.67	6.1	5.82	3.74	Upgrade
Other Operating Activities	-4.52	11.51	1.01	11.62	-2.98	Upgrade
Operating Cash Flow	-73.38	-48.4	-47.59	-21.78	-24.75	Upgrade
Change in Investments	-179.09	54.75	37.96	41.57	7.46	Upgrade
Investing Cash Flow	-179.09	54.75	37.96	41.57	7.46	Upgrade
Share Issuance / Repurchase	278.5	5.7	7.59	1.27	1.11	Upgrade
Other Financing Activities	-7.12	-1.53	-0.71	-0.32	-0.22	Upgrade
Financing Cash Flow	271.38	4.16	6.88	0.95	0.89	Upgrade
Exchange Rate Effect	-0.03	-0.26	0	0	0	Upgrade
Net Cash Flow	18.91	10.52	-2.75	20.74	-16.4	Upgrade
Free Cash Flow	-73.38	-48.4	-47.59	-21.78	-24.75	Upgrade
Free Cash Flow Per Share	-0.78	-0.63	-0.62	-0.30	-0.34	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).